In a recent podcast, Motley Fool CEO Tom Gardner discusses separating AI contenders from pretenders, favorite market indicators, and lessons from the dot-com bubble. He also shares six stock ideas for the next five years. To catch full episodes of all The Motley Fool’s podcasts, check out their podcast center.

Could AI create the world’s first trillionaire? A report on an “Indispensable Monopoly” company providing critical technology for Nvidia and Intel has been released. Details can be found in the full transcript below. Stock Advisor analysts identified the 10 best stocks to buy now, excluding TransMedics Group.

In the podcast, Tom Gardner highlights TransMedics as one of his favorite stocks for the next five years. He discusses the company’s organ care system and CEO, projecting a potential 3X increase in stock value over the next 6-7 years. TransMedics ticker symbol is TRMD.

Tom Gardner shares insights on determining AI contenders, market indicators, and future stock ideas. He emphasizes the importance of cultural change and technological advancements in companies to stay competitive. Gardner suggests looking for companies fully embracing AI in their workplace and industry leaders in AI technology.

Gardner uses two primary market indicators, the Potential Growth Indicator (PGI) and Market View Tool, to guide his investment decisions. The PGI measures cash flow in and out of the market, while the Market View Tool considers various data sources to predict market performance. Gardner predicts annual returns between 8.5% to 11% for US equity markets.

Looking ahead to the next five years, Gardner shares six stock ideas: MSCI, Deere, Intel, United Therapeutics, TransMedics, and Aritzia. These stocks range from cautious to aggressive picks, each with unique growth opportunities and strong financial fundamentals. Gardner also discusses Medpace as a potential growth stock in the biotech sector.

Read more at Yahoo Finance: 6 Stock Ideas for the Next 5 Years